|
A system service check of the medrad® stellant ct injection system (sn (b)(4)), was completed by bayer service on march 31, 2022, which confirmed that the injector was operating within specification.The disposables that were in use during the procedure were discarded by the site and lot numbers were unable to be provided; therefore, testing of retained samples is unable to be performed at this time.An offer for additional clinical applications training has been declined by the customer at this time.This information does not constitute an admission that the device, the company, or its employees caused or contributed to a reportable event.
|